Skip to main content

Table 2 Secondary endpoints

From: A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer

Secondary endpoints
• Local control and recurrence patterns of colorectal liver metastasis
• Progression free survival
• Surgical morbidity in patients undergoing liver resection who received this protocol treatment
• 30 day postoperative mortality
• Radiation toxicity
• Quality of life according to EORTC QoL questionnaire after 3 and 6 months